Building Bridges in Pharma: How We’re Powering Korea’s Research Efforts

We are proud to share that our company has successfully supplied Doxylamine Succinate to several major pharmaceutical companies in South Korea for their research and development (R&D) initiatives.

This collaboration marks another milestone in our commitment to bridging the pharmaceutical industries of India and South Korea, facilitating high-quality, compliant, and reliable ingredient supply for global innovation. To ensure uncompromised quality and reliability, this material was sourced directly from Malladi Drugs & Pharmaceuticals Ltd., one of India’s most trusted and reputed API manufacturers. Doxylamine Succinate is a first-generation antihistamine commonly used in formulations for sleep aid, allergy relief, and combination therapies. Its continued use in pharmaceutical research underscores its importance in formulation science and product development. As a trusted trading company, we specialize in sourcing and supplying pharmaceutical raw materials and active ingredients (APIs) from India’s leading manufacturers to global markets. By ensuring regulatory compliance, quality assurance, and seamless logistics, we enable our partners to focus on what they do best — developing the next generation of healthcare solutions.